A pilot trial of pramlintide home usage in adolescents with type 1 diabetes

Pediatrics

Volumn 124, Issue 5, 2009, Pages 1344-1347

  Kishiyama, Christopher M ^a   Burdick, Patricia L ^a   Cobry, Erin C ^a   Gage, Victoria L ^a   Messer, Laurel H ^a   McFann, Kim ^a   Chase, H Peter ^a  

^a Children's Hospital Colorado   (United States)

Author keywords

Adolescents; Pramlintide; Type1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; PRAMLINTIDE;

ADOLESCENCE; ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; BOOTSTRAPPING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; DRUG DOSE TITRATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; MALE; MEAL; NAUSEA; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; AMYLOID; AREA UNDER CURVE; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN INFUSION SYSTEMS; MALE; POSTPRANDIAL PERIOD;

EID: 70350475660     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-3750     Document Type: Article

References (13)

1. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose. Diabetes Care. 2001;24(11):1858-1862
2. Chase HP. Glycemic control in prepubertal years. Diabetes Care. 2003; 26(4):1304-1305
3. Koda JE, Fineman M, Rink TJ, Dailey GE, Muchmore DB, Linarelli LG. Amylin concentrations and glucose control. Lancet. 1992;339(8802):1179-1180
4. Fineman MS, Koda JE, Shen LZ, et al. The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes. Metabolism. 2002;51(5):636-641 (Pubitemid 34516520)
5. Kong MF, Stubbs TA, King P, et al. The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM. Diabetologia. 1998;41(5):577-583 (Pubitemid 28206829)
6. Chapman I, Parker B, Doran S, et al. Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes. Diabetologia. 2005;48(5):838-848 (Pubitemid 40767975)
7. Diabetes Research Network in Children Study Group. Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC Central Laboratory Assay: results of a Diabetes Research Network in Children (DirecNet) Study. Pediatr Diabetes. 2005;6(1):13-16
8. Brown RJ, Sinaii N, Rother KI. Too much glucagon, too little insulin. Diabetes Care. 2008;31(7):1403-1404
9. Chase HP, Lutz K, Pencek R, Zhang B, Porter L. Pramlintide-lowered glucose excursions and was well-tolerated in adolescents with type 1 diabetes: results from a randomized, singleblind, placebo-controlled, crossover study. J Pediatr. 2009;155(3):368-373.
10. Burdick J, Chase HP, Slover RH, et al. Missed insulin meal boluses and elevated hemoglobin A1c levels in children receiving insulin pump therapy. Pediatrics. 2004;113(3). Available at: www.pediatrics.org/cgi/content/full/113/ 3/e221
11. Neumark-Sztainer D, Patterson J, Mellin A, et al. Weight control practices and disordered eating behaviors among adolescent females and males with type 1 diabetes: associations with sociodemographics, weight concerns, familial factors, and metabolic outcomes. Diabetes Care. 2002;25(8):1289-1296 (Pubitemid 41071134)
12. Heptulla RA, Rodriguez LM, Bomgaars L, Haymond MW. The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes. Diabetes. 2005;54(4):1100-1107 (Pubitemid 40446324)
13. Rodriguez LM, Mason KJ, Haymond MW, Heptulla RA. The role of prandial pramlintide in the treatment of adolescents with type 1 diabetes. Pediatr Res. 2007;62(6):746-749 (Pubitemid 350158818)